[Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland]. [electronic resource]
Producer: 20041026Description: 456-66 p. digitalISSN:- 0004-4172
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- adverse effects
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Cohort Studies
- Disease Progression
- Endpoint Determination
- Female
- Humans
- Middle Aged
- Mistletoe
- Phytotherapy -- adverse effects
- Plant Extracts -- therapeutic use
- Proportional Hazards Models
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; English Abstract; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.